Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

GMED 21.66 0.00 (0.00%)
price chart
Shares of Globus Medical, Inc. (NYSE:GMED) Sees Large Inflow of Net Money
Globus Medical, Inc. (NYSE:GMED) traded negative at $21.37. On an intraday basis, the price dropped -0.02 points or -0.09%.
Company Shares of Globus Medical, Inc. (NYSE:GMED) Drops by -3.21%
Globus Medical, Inc. (NYSE:GMED) has lost 3.21% during the past week and dropped 8.47% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 4.21%.
Globus Medical Inc (NYSE:GMED) faces Lawsuit by Investor over alleged ...
Where is Globus Medical, Inc. (NYSE:GMED)s Stock Headed?  Markets Daily
Globus Medical, Inc. (NYSE:GMED) Analyst Rating Update
Analysts at Zacks have given a short term rating of buy on Globus Medical, Inc. (NYSE:GMED) with a rank of 2. The shares have received an average rating of 1.06 from 9 brokerage firms.
Globus Medical, Inc. (NYSE:GMED) Price Target Update
Globus Medical, Inc. (NYSE:GMED): 7 analysts have set the short term price target of Globus Medical, Inc. (NYSE:GMED) at $32. The standard deviation of short term price target has been estimated at $1.29, implying that the actual price may fluctuate by ...
Brokerage Firm Ratings Update on Globus Medical, Inc. (NYSE:GMED)  Investor Newswire
Globus Medical Sees Large Volume Increase (GMED)  DC Progressive
Globus Medical, Inc. (NYSE:GMED) a Top Growth Pick
Globus Medical, Inc. (NYSE:GMED) has received a top Growth Style score from Zack's Research. The growth score is based on company financials as well as the company's prospects for future growth.
Globus Medical, Inc. Short Interest Update  Insider Trading Report
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Globus ...
NEW YORK, Oct. 2, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Globus Medical, Inc. ("Globus Medical") (NYSE:GMED) between ...
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
GPM Files Securities Class Action Lawsuit Against Globus Medical, Inc.
Globus is a medical device company that develops products to treat patients with musculoskeletal disorders. The Company is currently focused on products to treat patients with spine disorders. On August 5, 2014, Globus issued a press release announcing ...
Enter your email address:  Stockhouse
Globus Medical Inc (NYSE:GMED) Is Now Covered by Morgan Stanley. They Set a ...
Morgan Stanley analyst has initiated coverage with a Overweight rating on Globus Medical Inc (NYSE:GMED) today and set a price target of $32.00.
Globus Medical (GMED) is Initiated by Morgan Stanley to Overweight, Price ...  Money Flow Index
Company Shares of Globus Medical, Inc. (NYSE:GMED) Drops by -10.49%  Insider Trading Report
Globus Medical Announces Key Executive Changes
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced a new leadership structure to enhance organizational alignment and continue the Company's industry leading ...
Zacks Rating on Globus Medical, Inc. (NYSE:GMED)  Insider Trading Report
Analysts Give $25 to $34 Target on Globus Medical, Inc. (NYSE:GMED)  Markets Daily